Pages that link to "Q34659193"
Jump to navigation
Jump to search
The following pages link to Species differences in pharmacokinetics and drug teratogenesis (Q34659193):
Displaying 50 items.
- Selecting exposure parameters in developmental neurotoxicity assessments (Q23910240) (← links)
- Developmental toxicology of industrial alcohols: a summary of 13 alcohols administered by inhalation to rats (Q23910245) (← links)
- Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations (Q24814147) (← links)
- The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. (Q30490602) (← links)
- Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. (Q30835700) (← links)
- A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan (Q33433352) (← links)
- Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats (Q33700983) (← links)
- Problems in testing and risk assessment of endocrine disrupting chemicals with regard to developmental toxicology (Q33722954) (← links)
- Analysis of reproductive toxicity and classification of glufosinate-ammonium (Q33993865) (← links)
- Anti-TNF-alpha therapies: the next generation (Q34227176) (← links)
- Corticosteroid use and risk of orofacial clefts (Q34819115) (← links)
- Reproductive and developmental toxicity of the components of gasoline (Q34849695) (← links)
- Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established (Q35127991) (← links)
- Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepilepti (Q35690870) (← links)
- Influence of co-medication on the metabolism of valproate (Q35690874) (← links)
- Voluntary exercise together with oral caffeine markedly stimulates UVB light-induced apoptosis and decreases tissue fat in SKH-1 mice (Q35921745) (← links)
- Evaluation of developmental toxicants and signaling pathways in a functional test based on the migration of human neural crest cells (Q36229064) (← links)
- Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis (Q36339894) (← links)
- Animal Models of Opiate, Cocaine, and Cannabis Use (Q36385672) (← links)
- Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms (Q37011415) (← links)
- Milk transfer and toxicokinetics of valproic Acid in lactating cynomolgus monkeys. (Q37326490) (← links)
- Placenta transfer and toxicokinetics of valproic Acid in pregnant cynomolgus monkeys (Q37326643) (← links)
- Drug transporters in the human blood-placental barrier (Q37395889) (← links)
- Image analysis of Ca2+ signals as a basis for neurotoxicity assays: promises and challenges (Q37531157) (← links)
- Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study (Q37678405) (← links)
- Constructing and Deconstructing Stem Cell Models of Neurological Disease (Q37879269) (← links)
- Guidance on classification for reproductive toxicity under the globally harmonized system of classification and labelling of chemicals (GHS). (Q38165989) (← links)
- Potential human developmental toxicants and the role of animal testing in their identification and characterization (Q38625359) (← links)
- Embryonic stem cells and the next generation of developmental toxicity testing. (Q38698182) (← links)
- In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities (Q38753758) (← links)
- Prenatal exposure to environmental factors and congenital limb defects (Q38987429) (← links)
- Vertebrate embryos as tools for anti-angiogenic drug screening and function. (Q39020240) (← links)
- The consequences of prenatal substance use for the developing fetus, newborn, and young child (Q40385860) (← links)
- Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line (Q40900025) (← links)
- Blood alcohol concentration and severity of microencephaly in neonatal rats depend on the pattern of alcohol administration (Q41932387) (← links)
- The effect of administering ethanol as single vs. divided doses on blood alcohol levels in the rat. (Q44071537) (← links)
- Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. (Q44520692) (← links)
- Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. (Q44633449) (← links)
- An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam (Q44778320) (← links)
- Anti-angiogenic effects of thalidomide: expression of apoptosis-inducible active-caspase-3 in a three-dimensional collagen gel culture of aorta (Q44954792) (← links)
- Folate supplementation of cyclophosphamide-treated mothers diminishes micronucleated erythrocytes in peripheral blood of newborn rats. (Q44996605) (← links)
- sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain. (Q47360266) (← links)
- Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitro (Q47792826) (← links)
- The pharmacokinetics of phenylethyl alcohol (PEA): safety evaluation comparisons in rats, rabbits, and humans (Q50761012) (← links)
- Oral and dermal developmental toxicity studies of phenylethyl alcohol in rats (Q50761013) (← links)
- Fetal and maternal cocaine levels peak rapidly following intragastric administration in the rat. (Q51743515) (← links)
- Developmental toxicity of indium in cultured rat embryos. (Q52176295) (← links)
- Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency. (Q52189504) (← links)
- Estimation of neonatal exposure after accidental ingestion of lufenuron in a breastfeeding mother. (Q52585355) (← links)
- The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-r (Q53019029) (← links)